Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.19.3
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 8,741 $ 2,671
Short-term investments 5,000  
Deferred financing costs 61 1,702
Prepaid expenses and other current assets 76 152
Total Assets 13,878 4,525
Current Liabilities:    
Accounts payable and accrued expenses 1,901 4,669
Accounts payable and accrued expenses - related party 16 487
Total current liabilities 1,917 5,156
Total Liabilities 1,917 5,156
Commitments and Contingencies
Stockholders' Equity (Deficit)    
Common Stock ($0.0001 par value), 50,000,000 shares authorized Common shares; 16,661,355 and 10,667,714 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 2 1
Additional paid-in capital 74,661 41,577
Accumulated deficit (62,702) (42,209)
Total Stockholders' Equity (Deficit) 11,961 (631)
Total Liabilities and Stockholders' Equity (Deficit) 13,878 4,525
Series A Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred Stock ($0.0001 par value), 2,000,000 shares authorized Class A Preferred Stock, 250,000 shares issued and outstanding as of September 30, 2019 and December 31, 2018 $ 0 $ 0